Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity <i>In Vitro</i>-Reference-Cited by-同舟云学术

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro

Published:2023-06-15 Issue:3 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Li Anqi¹²,He Siyuan¹²,Li Jingren¹²,Zhang Zhemin¹²,Li Bing¹²,Chu Haiqing¹²³^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China

2. School of Medicine, Tongji University, Shanghai, China

3. Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China

Abstract

The antimicrobial activities of four third-generation tetracycline-class drugs, omadacycline (OMC), eravacycline (ERC), tigecycline (TGC), and sarecycline (SAC), were determined for 193 M. abscessus isolates. The activities of the four drugs at two different temperatures (30°C and 37°C) were also tested.

Funder

MOST | National Natural Science Foundation of China

Natural Science Foundation of Shanghai

Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Zhongnanshan Medical Foundation of Guangdong Province

Clinical Research Foundation of Shanghai Pulmonary Hospital

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00718-23